Moreover, Stevic et al. reported that the plasma levels of six miRNAs (-185-5p, -376a-3p, -382-5p, -410-3p, -433-3p, and -628-5p) were significantly associated with a higher tumor stage (i.e., T3-T4 versus T1-T2) in a cohort of HER2-positive BC patients [43]. Here, ERBB2 is linked to breast cancer.